Zhejiang Int'L Group Co Ltd Asset Resilience Ratio
Zhejiang Int'L Group Co Ltd asset resilience ratio. Zhejiang Int'L Group Co Ltd (000411) has an Asset Resilience Ratio of 0.00% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Zhejiang Int'L Group Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Int'L Group Co Ltd (1993–2022)
Asset resilience ratio of Zhejiang Int'L Group Co Ltd from 1993 to 2022. This chart shows how Zhejiang Int'L Group Co Ltd's Asset Resilience Ratio has changed over time. Read Zhejiang Int'L Group Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Int'L Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000411 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.00 | 0.0% |
| Total Liquid Assets | CN¥1.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Int'L Group Co Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Int'L Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Int'L Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Merck & Company Inc
NYSE:MRK |
Drug Manufacturers - General | 0.22% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.33% |
|
Novo Nordisk A/S
CO:NOVO-B |
Drug Manufacturers - General | 0.09% |
|
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
Drug Manufacturers - General | 0.07% |
|
AstraZeneca PLC
F:ZEGA |
Drug Manufacturers - General | 0.03% |
Zhejiang Int'L Group Co Ltd Asset Resilience Ratio by Year (1993–2022)
Zhejiang Int'L Group Co Ltd asset resilience ratio by year from 1993 to 2022. The table below shows the annual Asset Resilience Ratio data for Zhejiang Int'L Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | -1.28% | CN¥-168.87 Million ≈ $-24.71 Million |
CN¥13.16 Billion ≈ $1.93 Billion |
+0.60pp |
| 2021-12-31 | -1.88% | CN¥-230.20 Million ≈ $-33.69 Million |
CN¥12.25 Billion ≈ $1.79 Billion |
+0.32pp |
| 2020-12-31 | -2.20% | CN¥-247.16 Million ≈ $-36.17 Million |
CN¥11.25 Billion ≈ $1.65 Billion |
+0.19pp |
| 2019-12-31 | -2.39% | CN¥-257.34 Million ≈ $-37.66 Million |
CN¥10.77 Billion ≈ $1.58 Billion |
-1.52pp |
| 2018-12-31 | -0.87% | CN¥-78.28 Million ≈ $-11.46 Million |
CN¥8.99 Billion ≈ $1.32 Billion |
-0.13pp |
| 2017-12-31 | -0.74% | CN¥-67.63 Million ≈ $-9.90 Million |
CN¥9.08 Billion ≈ $1.33 Billion |
+0.31pp |
| 2016-12-31 | -1.06% | CN¥-73.89 Million ≈ $-10.81 Million |
CN¥6.99 Billion ≈ $1.02 Billion |
+0.02pp |
| 2015-12-31 | -1.07% | CN¥-65.77 Million ≈ $-9.62 Million |
CN¥6.12 Billion ≈ $896.28 Million |
-1.08pp |
| 2013-12-31 | 0.01% | CN¥248.89K ≈ $36.42K |
CN¥4.80 Billion ≈ $702.04 Million |
0.00pp |
| 2012-12-31 | 0.01% | CN¥269.31K ≈ $39.41K |
CN¥4.11 Billion ≈ $601.45 Million |
+0.00pp |
| 2011-12-31 | 0.01% | CN¥237.12K ≈ $34.70K |
CN¥3.68 Billion ≈ $538.36 Million |
+0.01pp |
| 2001-12-31 | 0.00% | CN¥2.00K ≈ $292.66 |
CN¥599.40 Million ≈ $87.71 Million |
-0.02pp |
| 2000-12-31 | 0.02% | CN¥57.00K ≈ $8.34K |
CN¥292.30 Million ≈ $42.77 Million |
+0.02pp |
| 1996-12-31 | 0.00% | CN¥12.51K ≈ $1.83K |
CN¥488.64 Million ≈ $71.50 Million |
-0.04pp |
| 1995-12-31 | 0.04% | CN¥147.38K ≈ $21.57K |
CN¥383.42 Million ≈ $56.11 Million |
-0.16pp |
| 1994-12-31 | 0.20% | CN¥576.90K ≈ $84.42K |
CN¥288.35 Million ≈ $42.20 Million |
-1.92pp |
| 1993-12-31 | 2.12% | CN¥5.10 Million ≈ $746.29K |
CN¥240.07 Million ≈ $35.13 Million |
-- |
About Zhejiang Int'L Group Co Ltd
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.